CN Stock MarketDetailed Quotes
300149 ChemPartner PharmaTech
- 6.40
- -0.21-3.18%
Market Closed Nov 18 15:00 CST
3.20BMarket Cap-3377P/E (TTM)
6.79High6.30Low152.67KlotVolume6.62Open6.61Pre Close98.00MTurnover3.06%Turnover RatioLossP/E (Static)499.78MShares9.0352wk High2.34P/B3.19BFloat Cap3.6852wk Low7.93Limit Up498.90MShs Float28.27Historical High5.29Limit Down7.41%Amplitude2.25Historical Low--Dividend TTM6.42Avg Price79.69KlotAsk--Div YieldTTM100Lot Size68.70KlotBid
ChemPartner PharmaTech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.09%718.53M | -16.56%465.16M | -12.68%234.59M | -14.19%1.14B | -18.02%846.18M | -18.84%557.45M | -30.45%268.66M | -21.54%1.33B | -18.17%1.03B | -18.75%686.9M |
| Operating revenue | -15.09%718.53M | -16.56%465.16M | -12.68%234.59M | -14.19%1.14B | -18.02%846.18M | -18.84%557.45M | -30.45%268.66M | -21.54%1.33B | -18.17%1.03B | -18.75%686.9M |
| Other operating revenue | ---- | -16.47%2.45M | ---- | --6.5M | ---- | -60.89%2.93M | ---- | ---- | ---- | 158.66%7.5M |
| Total operating cost | -11.99%774.22M | -8.67%525.1M | -12.26%263.46M | -14.95%1.2B | -11.57%879.74M | -19.39%574.96M | -18.62%300.28M | -17.08%1.41B | -21.11%994.88M | -15.83%713.3M |
| Operating cost | -8.72%580.39M | -7.03%389.33M | 0.44%193.14M | -14.78%843.13M | -3.70%635.86M | -6.93%418.76M | -17.63%192.28M | -14.34%989.33M | -24.07%660.31M | -25.16%449.95M |
| Operating tax surcharges | 31.78%4.08M | 12.85%3.14M | 250.94%970.46K | -24.22%5.67M | -56.69%3.09M | -34.24%2.78M | -73.94%276.53K | 31.57%7.48M | 116.86%7.14M | 95.22%4.23M |
| Operating expense | -15.75%28.33M | -2.87%21.08M | 7.95%11M | -26.27%45.6M | -29.35%33.63M | -40.73%21.7M | -44.00%10.19M | -2.72%61.85M | 7.43%47.6M | 27.86%36.62M |
| Administration expense | -24.38%108.03M | -17.41%77.68M | -34.66%39.21M | -13.70%212.55M | -34.70%142.86M | -35.43%94.05M | -11.55%60M | -8.13%246.3M | 13.15%218.79M | 25.34%145.67M |
| Financial expense | 49.02%8.11M | 396.09%1.71M | -86.42%2.25M | 18.71%14.02M | 128.26%5.44M | -98.22%343.82K | -17.33%16.58M | -85.65%11.81M | -132.36%-19.24M | -52.42%19.36M |
| -Interest expense (Financial expense) | -32.07%2.91M | -36.71%2.14M | -59.31%1.06M | -52.92%31.3M | -83.06%4.29M | -83.61%3.38M | -77.56%2.61M | -15.56%66.48M | -33.29%25.3M | -48.04%20.63M |
| -Interest Income (Financial expense) | 37.16%-7.17M | 46.16%-4.66M | 67.76%-2.28M | -25.22%-14.79M | -86.29%-11.41M | -1,328.37%-8.66M | -2,653.92%-7.07M | -216.89%-11.81M | -134.79%-6.12M | 64.39%-606.54K |
| Research and development | -23.07%45.28M | -13.81%32.17M | -19.33%16.9M | -16.05%77.47M | -26.69%58.85M | -35.06%37.32M | -26.22%20.95M | -25.97%92.28M | -11.77%80.28M | -1.80%57.47M |
| Credit Impairment Loss | -991.81%-14.76M | -284.46%-11.88M | 161.38%272.3K | 69.63%-6.07M | 57.21%-1.35M | 45.74%-3.09M | 92.89%-443.59K | -794.19%-20M | -366.06%-3.16M | -2,226.40%-5.69M |
| Asset Impairment Loss | -379.07%-13.63M | -21.17%-3.38M | -27.12%-1.94M | -59.60%-877.87M | -48.33%-2.84M | 12.26%-2.79M | 5.80%-1.52M | -48.06%-550.03M | 36.81%-1.92M | 25.12%-3.18M |
| Other net revenue | -224.21%-10.87M | -271.80%-9.73M | -50.27%1.6M | -205.58%-876.29M | -99.36%8.75M | -99.58%5.67M | 154.83%3.22M | 339.31%829.99M | 10,582.62%1.36B | 40,370.30%1.35B |
| Fair value change income | 100.45%1.65K | --0 | ---- | --0 | -756.37%-364.95K | -484.80%-249.22K | --0 | -167.79%-42.62K | ---42.62K | ---42.62K |
| Invest income | -28.86%7.3M | -69.61%2.5M | -47.35%1.73M | -100.07%-922.4K | -99.25%10.26M | -99.39%8.23M | 645.26%3.28M | 12,557.71%1.39B | 27,953.66%1.36B | 30,542.64%1.36B |
| Net open hedge income | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Investment income associates | -27.09%7.07M | -69.65%2.35M | -44.69%1.72M | -382.83%-1.53M | 18.48%9.7M | 48.92%7.76M | 751.89%3.11M | -2,054.88%-317.14K | 94.07%8.19M | 29.76%5.21M |
| Asset deal income | 334.27%3.62M | 454.27%48.13K | ---- | 99.73%-412.39 | -371.17%-1.55M | 93.38%-13.59K | --0 | -615.27%-154.77K | -4,368.88%-328.12K | -2,694.95%-205.21K |
| Other revenue | 43.55%6.59M | -16.84%2.98M | -19.25%1.54M | -6.55%8.57M | -34.23%4.59M | 14.46%3.58M | 17.44%1.9M | -42.20%9.17M | -28.40%6.98M | 7.86%3.13M |
| Operating profit | -168.29%-66.56M | -488.58%-69.67M | 4.01%-27.27M | -225.26%-936.36M | -101.77%-24.81M | -100.89%-11.84M | -348.12%-28.41M | 310.33%747.52M | 10,537.68%1.4B | 106,159.01%1.32B |
| Add:Non operating Income | -90.87%29.12K | -91.00%20.15K | -44.20%67.99K | 159.75%815.88K | 86.91%319.05K | 82.61%224.04K | 127.68%121.85K | -30.82%314.1K | -52.30%170.7K | -56.29%122.68K |
| Less:Non operating expense | 677.25%510.06K | 571.32%405.33K | 75,397.43%239.55K | -77.89%4.22M | -89.53%65.62K | -83.35%60.38K | -99.37%317.3 | 213.71%19.08M | -32.50%626.76K | -59.72%362.71K |
| Total profit | -173.02%-67.04M | -500.13%-70.06M | 2.99%-27.44M | -228.95%-939.77M | -101.76%-24.55M | -100.88%-11.67M | -347.00%-28.29M | 301.86%728.76M | 11,016.81%1.4B | 211,304.46%1.32B |
| Less:Income tax cost | -176.02%-5.26M | -302.71%-7.08M | 37.67%-1.94M | -106.23%-22.83M | -98.16%6.91M | -99.05%3.49M | -252.94%-3.11M | 792.07%366.34M | 17,782.01%374.87M | 8,512.22%367.22M |
| Net profit | FPtoL-61.78M | FPtoL-62.98M | FPtoL-25.5M | SL-916.94M | SL-31.47M | SL-15.17M | SL-25.17M | FLtoP362.42M | 6,862.37%1.02B | 19,063.16%956.54M |
| Net profit from continuing operation | -96.33%-61.78M | -315.30%-62.98M | -1.29%-25.5M | -353.01%-916.94M | -103.08%-31.47M | -101.59%-15.17M | -367.33%-25.17M | 190.13%362.42M | 6,862.37%1.02B | 19,063.16%956.54M |
| Less:Minority Profit | 20.83%-115.34K | -6.27%-73.71K | -36.66%-39.2K | 10.00%-186.3K | 11.10%-145.68K | -47.02%-69.36K | 47.13%-28.68K | -239.56%-206.99K | -19.95%-163.88K | 67.76%-47.18K |
| Net profit of parent company owners | -96.88%-61.67M | -316.72%-62.91M | -1.25%-25.46M | -352.81%-916.75M | -103.06%-31.32M | -101.58%-15.1M | -365.50%-25.15M | 190.15%362.63M | 6,799.35%1.02B | 18,518.34%956.58M |
| Earning per share | ||||||||||
| Basic earning per share | -100.00%-0.12 | -333.33%-0.13 | 0.00%-0.05 | -352.05%-1.84 | -102.93%-0.06 | -101.56%-0.03 | -350.00%-0.05 | 190.12%0.73 | 6,779.19%2.05 | 18,540.78%1.92 |
| Diluted earning per share | -100.00%-0.12 | -333.33%-0.13 | 0.00%-0.05 | -352.05%-1.84 | -102.93%-0.06 | -101.56%-0.03 | -350.00%-0.05 | 190.12%0.73 | 6,779.19%2.05 | 18,540.78%1.92 |
| Other composite income | -194.32%-9.43M | -111.70%-1.14M | 134.65%1.88M | -66.81%7.82M | -65.76%10M | -17.16%9.79M | -530.58%-5.41M | 507.32%23.57M | 4,446.97%29.22M | 718.75%11.81M |
| Other composite income of parent company owners | -194.32%-9.43M | -111.70%-1.14M | 134.65%1.88M | -66.81%7.82M | -65.76%10M | -17.16%9.79M | -530.58%-5.41M | 507.32%23.57M | 4,446.97%29.22M | 718.75%11.81M |
| Total composite income | -231.75%-71.22M | -1,092.09%-64.13M | 22.77%-23.62M | -335.53%-909.12M | -102.04%-21.47M | -100.56%-5.38M | -457.42%-30.59M | 194.63%385.99M | 7,404.34%1.05B | 31,316.11%968.35M |
| Total composite income of parent company owners | -233.48%-71.1M | -1,106.27%-64.05M | 22.82%-23.58M | -335.36%-908.93M | -102.03%-21.32M | -100.55%-5.31M | -454.83%-30.56M | 194.65%386.19M | 7,333.10%1.05B | 29,893.84%968.4M |
| Total composite income of minority owners | 20.83%-115.34K | -6.27%-73.71K | -36.66%-39.2K | 10.00%-186.3K | 11.10%-145.68K | -47.02%-69.36K | 47.13%-28.68K | -239.56%-206.99K | -19.95%-163.88K | 67.76%-47.18K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data